Savara Inc. (SVRA) News

Latest headlines that mention SVRA, newest first · each headline opens the original publisher

SVRA quote

Last price: $4.83
Day change: +10.27%
Next earnings: 2026-11-11

Quote & chart Expected move Insider trading IV rank history

SVRA headlines

latest coverage

Not much coverage yet. SVRA has appeared in only a few headlines lately; new stories show up here as publishers cover it.

Investing.com 1mo ago

Citizens reiterates Savara stock rating on Molbreevi launch outlook

General T3SVRA

Investing.com 2mo ago

Savara presents molgramostim data at ERS Congress in September

General T3SVRA

Seeking Alpha News 3mo ago

Savara: High Potential Binary Bet Cruising To PDUFA After 3 Month Speed Bump

General T2SVRA

Investing.com 3mo ago

Form 4 Savara Inc For: 24 July

General T3SVRA

Motley Fool 4mo ago

What Savara Investors Should Know About This 580,187-Option Exercise and FDA Timeline

This clinical-stage biotech focused on rare lung diseases reported significant insider selling amid a year of strong share gains.

General T3SVRA

Investing.com 4mo ago

Form 144 Savara Inc For: 22 June

General T3SVRA

Seeking Alpha 5mo ago

Savara CFO to step down

General T2SVRA

Seeking Alpha News 5mo ago

Savara: The Rare Disease Funnel Is Becoming A Commercial Asset

General T2SVRA

Yahoo Finance 5mo ago

Savara Inc. (SVRA) Reports Q1 Financial Results

General T2SVRA

Seeking Alpha 5mo ago

Savara GAAP EPS of -$0.15 misses by $0.01

Earnings T2SVRA

SVRA news alerts

Get an alert by email or push when a new headline mentions SVRA.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.